Obesity in the Cardiovascular Continuum

E-ISSN： 2212-3938|8|2|159-163

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.8, Iss.2, 2013-05, pp. : 159-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Treatment of Obesity in Cardiovascular Disease

By Charakida Marietta Finer Nicholas

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 2, 2012-04 ,pp. : 93-104

Adis International

Access to resources Recommend Favorite

Inflammation, Adiponectin, Obesity and Cardiovascular Risk

Current Medicinal Chemistry, Vol. 17, Iss. 36, 2010-12 ,pp. : 4511-4520

Bentham Science Publishers

Access to resources Recommend Favorite

RAAS Inhibitors in the Cardiovascular Continuum: What is Still Missing?

By Maggioni Aldo P. Latini Roberto

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 4, 2004-07 ,pp. : 311-320

Springer Publishing Company

Access to resources Recommend Favorite

Candidate Circulating Biomarkers for the Cardiovascular Disease Continuum

Current Pharmaceutical Design, Vol. 14, Iss. 24, 2008-08 ,pp. : 2445-2461

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular consequences of the obesity pandemic: need for action

By Barton Matthias Furrer Jörg

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. : 1757-1759

Informa Healthcare

Access to resources Recommend Favorite